IS8941A - Efnasambönd með bólgueyðandi virkni - Google Patents

Efnasambönd með bólgueyðandi virkni

Info

Publication number: IS8941A
Authority: IS; Iceland
Prior art keywords: compounds; inflammatory activity; inflammatory; activity
Prior art date: 2003-04-24

Application number

IS8941A

Other languages

English (en)

Inventor

Mladen Mercep

Milan Mesic

Linda Tomaskovic

Stribor Markovic

Boska Hrvacic

Oresta Makaruha

Visnja Poljak

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2010-12-29

Publication date

2010-12-29

2010-12-29 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2010-12-29 Publication of IS8941A publication Critical patent/IS8941A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

IS8941A 2003-04-24 2010-12-29 Efnasambönd með bólgueyðandi virkni IS8941A (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HR20030324A HRP20030324A2 (en)	2003-04-24	2003-04-24	Compounds of antiinflammatory effect

Publications (1)

Publication Number	Publication Date
IS8941A true IS8941A (is)	2010-12-29

Family

ID=33307078

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS8141A IS2736B (is)	2003-04-24	2005-11-22	Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni
IS8941A IS8941A (is)	2003-04-24	2010-12-29	Efnasambönd með bólgueyðandi virkni

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IS8141A IS2736B (is)	2003-04-24	2005-11-22	Makrólíðsamrunaefnasambönd@með@bólgueyðandi@virkni

Country Status (27)

Country	Link
US (1)	US7579334B2 (is)
EP (2)	EP2070940B1 (is)
JP (1)	JP4613366B2 (is)
KR (1)	KR101107336B1 (is)
CN (1)	CN100393741C (is)
AR (1)	AR044083A1 (is)
AT (1)	ATE518876T1 (is)
AU (1)	AU2004232546B2 (is)
BR (1)	BRPI0410490A (is)
CA (1)	CA2523081C (is)
CL (1)	CL2004000872A1 (is)
CY (2)	CY1109491T1 (is)
DE (1)	DE602004022047D1 (is)
DK (2)	DK2070940T3 (is)
ES (2)	ES2330109T3 (is)
HR (3)	HRP20030324A2 (is)
IS (2)	IS2736B (is)
ME (1)	MEP34708A (is)
MX (1)	MXPA05011359A (is)
NO (2)	NO333909B1 (is)
PL (2)	PL2070940T3 (is)
PT (2)	PT1633771E (is)
RS (1)	RS52621B (is)
RU (1)	RU2355699C2 (is)
SI (2)	SI2070940T1 (is)
WO (1)	WO2004094449A1 (is)
ZA (1)	ZA200508388B (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR043050A1 (es)	2002-09-26	2005-07-13	Rib X Pharmaceuticals Inc	Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
EP2716647A3 (en)	2004-02-27	2014-08-20	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
BRPI0514254A (pt) *	2004-08-12	2008-06-03	Glaxosmithkline Zagreb	uso de conjugados célula-especìficos para o tratamento de doenças inflamatórias do trato gastrintestinal
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
ES2337915T3 (es)	2004-10-27	2010-04-30	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugados con adtividad antiinflamatoria.
ES2436225T3 (es)	2005-12-22	2013-12-27	Hydra Biosciences, Inc.	Inhibidores TRPA1 para tratamiento del dolor
WO2007093840A2 (en) *	2006-02-15	2007-08-23	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
CA2717456A1 (en) *	2008-03-05	2009-09-11	Panacea Biotec Limited	Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CN102838660B (zh) *	2011-06-23	2016-11-02	上海市第一人民医院	一种抑制炎症免疫反应的小肽及其应用
JP2016505038A (ja) *	2013-01-23	2016-02-18	スファエラファーマプライベートリミテッド	ミトコンドリア生合成ならびにミトコンドリア機能不全または欠乏に関連する疾患において使用するための１１β−ヒドロキシステロイドの新規の化合物
CA2899500A1 (en)	2013-03-08	2014-09-12	Allergan, Inc.	Cyclosporine a-steroid conjugates
BR112015021834A2 (pt) *	2013-03-08	2017-07-18	Allergan Inc	conjugados de antibióticos ligados com drogas esteroides
CN105073140A (zh)	2013-03-08	2015-11-18	阿勒根公司	与类固醇药物直接键联的抗生素缀合物
WO2014138343A1 (en) *	2013-03-08	2014-09-12	Allergan, Inc.	Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
CN106714770B (zh)	2014-07-23	2024-04-19	斯法尔制药私人有限公司	羟基类固醇化合物、其中间体、制备方法、组合物及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3779221D1 (de)	1986-08-19	1992-06-25	Genentech Inc	Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
DE3860503D1 (de)	1987-09-03	1990-10-04	Pliva Pharm & Chem Works	10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
SE9100341D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroids
SE9100342D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroid esters
GB9225923D0 (en)	1992-12-11	1993-02-03	Rhone Poulenc Rorer Ltd	New compositions of matter
HUT72442A (en)	1992-12-24	1996-04-29	Rhone Poulenc Rorer Ltd	Steroids condensed with heteroring containing oxygene, pharmaceutical compositions containing them and processes for their production
CA2196879A1 (en)	1994-08-12	1996-02-22	Akihiko Hoshino	Interleukin-5 production inhibitor
KR970704456A (ko)	1994-08-12	1997-09-06	우에하라 아끼라	인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
DE19616573C2 (de)	1996-04-25	1999-03-04	Pari Gmbh	Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JP3530004B2 (ja)	1998-02-06	2004-05-24	株式会社日立ユニシアオートモティブ	吸入式投薬器
JP2002528495A (ja) *	1998-10-30	2002-09-03	ニトロメドインコーポレーテッド	ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
IT1306205B1 (it)	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
HRP20000310A2 (en)	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors
FI110835B (fi)	2000-07-11	2003-03-31	Radiolinja Ab	Menetelmä palvelunumeropuhelun tarjoamiseksi matkaviestintilaajalle ennalta määrätyllä taksalla
HRP20010018A2 (en)	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
US20040005641A1 (en) *	2002-02-15	2004-01-08	Michael Burnet	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US20040186063A1 (en) *	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070174A2 (en)	2002-02-15	2003-08-28	Sympore Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
CA2489402A1 (en) *	2002-07-08	2004-01-15	Pliva-Istrazivacki Institut D.O.O.	New compounds, compositions and methods for treatment of inflammatory diseases and conditions
JP2005536488A (ja)	2002-07-08	2005-12-02	プリヴァ−イストラジヴァキ・インスティトゥ・ディー・オー・オー	新規な非ステロイド抗炎症物質、組成物、およびその使用方法
PL375162A1 (en) *	2002-07-08	2005-11-28	Pliva-Istrazivacki Institut D.O.O.	Novel compounds, compositions as carriers for steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect

2003
- 2003-04-24 HR HR20030324A patent/HRP20030324A2/hr not_active Application Discontinuation
2004
- 2004-04-22 US US10/830,858 patent/US7579334B2/en not_active Expired - Fee Related
- 2004-04-23 RS YU20050873A patent/RS52621B/sr unknown
- 2004-04-23 PT PT04729157T patent/PT1633771E/pt unknown
- 2004-04-23 DE DE602004022047T patent/DE602004022047D1/de not_active Expired - Lifetime
- 2004-04-23 CA CA2523081A patent/CA2523081C/en not_active Expired - Lifetime
- 2004-04-23 DK DK09075145.4T patent/DK2070940T3/da active
- 2004-04-23 AR ARP040101400A patent/AR044083A1/es unknown
- 2004-04-23 PL PL09075145T patent/PL2070940T3/pl unknown
- 2004-04-23 SI SI200431768T patent/SI2070940T1/sl unknown
- 2004-04-23 ME MEP-347/08A patent/MEP34708A/xx unknown
- 2004-04-23 HR HR20090551T patent/HRP20090551T1/hr unknown
- 2004-04-23 AT AT09075145T patent/ATE518876T1/de active
- 2004-04-23 ES ES04729157T patent/ES2330109T3/es not_active Expired - Lifetime
- 2004-04-23 CL CL200400872A patent/CL2004000872A1/es unknown
- 2004-04-23 DK DK04729157T patent/DK1633771T3/da active
- 2004-04-23 PT PT09075145T patent/PT2070940E/pt unknown
- 2004-04-23 KR KR1020057020252A patent/KR101107336B1/ko not_active Expired - Fee Related
- 2004-04-23 CN CNB2004800110487A patent/CN100393741C/zh not_active Expired - Fee Related
- 2004-04-23 SI SI200431253T patent/SI1633771T1/sl unknown
- 2004-04-23 JP JP2006506511A patent/JP4613366B2/ja not_active Expired - Fee Related
- 2004-04-23 BR BRPI0410490-0A patent/BRPI0410490A/pt not_active Application Discontinuation
- 2004-04-23 WO PCT/IB2004/001235 patent/WO2004094449A1/en not_active Ceased
- 2004-04-23 EP EP09075145A patent/EP2070940B1/en not_active Expired - Lifetime
- 2004-04-23 ES ES09075145T patent/ES2370371T3/es not_active Expired - Lifetime
- 2004-04-23 AU AU2004232546A patent/AU2004232546B2/en not_active Ceased
- 2004-04-23 MX MXPA05011359A patent/MXPA05011359A/es active IP Right Grant
- 2004-04-23 PL PL04729157T patent/PL1633771T3/pl unknown
- 2004-04-23 EP EP04729157A patent/EP1633771B1/en not_active Expired - Lifetime
- 2004-04-23 RU RU2005131937/04A patent/RU2355699C2/ru not_active IP Right Cessation
2005
- 2005-10-17 ZA ZA200508388A patent/ZA200508388B/xx unknown
- 2005-11-22 IS IS8141A patent/IS2736B/is unknown
- 2005-11-23 NO NO20055535A patent/NO333909B1/no not_active IP Right Cessation
2009
- 2009-10-14 CY CY20091101070T patent/CY1109491T1/el unknown
2010
- 2010-12-29 IS IS8941A patent/IS8941A/is unknown
2011
- 2011-10-19 HR HR20110763T patent/HRP20110763T1/hr unknown
- 2011-10-25 CY CY20111101008T patent/CY1111978T1/el unknown
2013
- 2013-06-28 NO NO20130898A patent/NO335552B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
SI1633771T1 (sl)	2009-12-31
PL2070940T3 (pl)	2011-12-30
HRP20090551T1 (hr)	2010-01-31
EP2070940A3 (en)	2009-11-25
HRP20110763T1 (hr)	2011-11-30
EP1633771B1 (en)	2009-07-15
NO335552B1 (no)	2014-12-29
ES2330109T3 (es)	2009-12-04
BRPI0410490A (pt)	2006-06-13
PL1633771T3 (pl)	2009-12-31
NO333909B1 (no)	2013-10-14
MXPA05011359A (es)	2006-05-12
CY1111978T1 (el)	2015-11-04
CA2523081C (en)	2010-08-03
CN100393741C (zh)	2008-06-11
NO20055535L (no)	2006-01-16
SI2070940T1 (sl)	2011-12-30
CY1109491T1 (el)	2014-08-13
RU2005131937A (ru)	2006-06-27
RS52621B (sr)	2013-06-28
CN1777619A (zh)	2006-05-24
EP1633771A1 (en)	2006-03-15
AR044083A1 (es)	2005-08-24
ZA200508388B (en)	2006-07-26
DK1633771T3 (da)	2009-11-16
IS2736B (is)	2011-06-15
DK2070940T3 (da)	2011-10-31
JP2006524221A (ja)	2006-10-26
RS20050873A (sr)	2007-08-03
HK1086842A1 (zh)	2006-09-29
HK1129681A1 (en)	2009-12-04
JP4613366B2 (ja)	2011-01-19
WO2004094449A8 (en)	2005-03-31
PT1633771E (pt)	2009-10-20
NO20055535D0 (no)	2005-11-23
US20050080003A1 (en)	2005-04-14
WO2004094449A1 (en)	2004-11-04
DE602004022047D1 (de)	2009-08-27
ES2370371T3 (es)	2011-12-14
NO20130898L (no)	2006-01-16
RU2355699C2 (ru)	2009-05-20
AU2004232546A1 (en)	2004-11-04
EP2070940B1 (en)	2011-08-03
US7579334B2 (en)	2009-08-25
EP2070940A1 (en)	2009-06-17
IS8141A (is)	2005-11-22
CL2004000872A1 (es)	2005-03-18
KR20060024770A (ko)	2006-03-17
KR101107336B1 (ko)	2012-01-19
CA2523081A1 (en)	2004-11-04
AU2004232546B2 (en)	2011-06-09
ATE518876T1 (de)	2011-08-15
PT2070940E (pt)	2011-11-14
MEP34708A (en)	2011-05-10
HRP20030324A2 (en)	2005-02-28

Publication	Publication Date	Title
IS8941A (is)	2010-12-29	Efnasambönd með bólgueyðandi virkni
DK1644398T3 (da)	2013-02-04	Specifik glucocorticosteroidforbindelse med antiinflammatorisk aktivitet
IS8403A (is)	2006-04-07	Pýrrólafleiður með bakteríueyðandi virkni
DE60304290D1 (de)	2006-05-18	Anti-Siphonvorrichtung
IS7471A (is)	2004-10-15	Ný efnasambönd
IS8108A (is)	2005-10-31	Ný efnasambönd
DK1605897T3 (da)	2012-08-20	Polyethelen-glycol-link-glp-1-forbindelser
ATE368042T1 (de)	2007-08-15	Cephemverbindungen
IS7879A (is)	2005-06-02	Ný efnasambönd
IS7381A (is)	2004-08-03	Efnasambönd
IS7414A (is)	2004-08-19	Oxó-azabísýklísk efnasambönd
IS8228A (is)	2006-01-11	Ný asetídínefnasambönd
NO20045659L (no)	2004-12-27	Forbindelser
IS7827A (is)	2005-04-27	Ný efnasambönd
NO20034599D0 (no)	2003-10-14	Brokonstruksjon
IS8292A (is)	2006-02-09	Ný efnasambönd
DK1594859T3 (da)	2010-10-11	Indazolamider med analgetisk aktivitet
DK1691814T3 (da)	2012-10-29	Antiinflammatoriske midler
IS8269A (is)	2006-01-26	Setin fúrókrómen efnasambönd með bólgueyðandi virkni
ITMI20040124A1 (it)	2004-04-29	Macrolidi ad attivita' antiinfiammatoria
NO20034600D0 (no)	2003-10-14	Brokonstruksjon
SE0303452D0 (sv)	2003-12-18	New compounds
FR2840006B1 (fr)	2005-01-21	Construction demontable
UA9218S (uk)	2004-08-16	Хрест із розп`яттям
SE0200523D0 (sv)	2002-02-21	New compounds